Innovation remains the DNA of the Precision Medicine and the Future of Genomics Summit
Sidra Medicine, a member of Qatar Foundation, unveils the official line-up of strategic partners, sponsors, and innovators participating in the upcoming Precision Medicine and the Future of Genomics (PMFG) Summitย from 2 to 4 December 2025 at Qatar National Convention Centre (QNCC).
Building on the Summitโs legacy as the regionโs leading platform for advancing personalized healthcare, PMFG 2025 will once again bring together global experts, research pioneers, industry leaders, and emerging innovators to explore breakthroughs shaping the future of precision medicine.
Prof. Khalid Fakhro, Chief Research Officer at Sidra Medicine said: โPMFG 2025 is a celebration of eleven years of scientific discovery and innovation in precision medicine. The summit highlights cutting-edge research and advances in genomics, healthcare technologies and clinical precision medicine implementation, bringing global expertise to the region.โ
Also Read: UNAIDS releases its 2025 World AIDS Day report
Partners and Sponsors Driving Global Collaboration
This yearโs Summit will be held in collaboration with key institutional and industry partners including the Qatar Precision Health Institute (QPHI); the Ministry of Communications and Information Technology (MCIT); Childrenโs Hospital of Philadelphia (CHOP) and Mass General Brigham Hospital (MGB), serving as Knowledge Partners. Invest Qatar and Qatar Free Zone join as strategic partners and titanium sponsors, while MedTech Corporation lead the sponsorship as Diamond Sponsors, alongside with CISCO, Quantinuum, GBM and Compass Qatar as Platinum sponsors.
Dr. Ammira Al-Shabeeb Akil, Scientific Outreach and Business Development Chair, PMFG Summit 2025, and Director of Mendelian and Metabolic Disorders Research Program, said: โOur focus has been on building the infrastructure that makes PMFG Summit 2025 a hub for innovation. From securing sponsors and partners to launching the Startups Hub, our goal is to give entrepreneurs and researchers the platform to showcase their work and translate ideas into real-world impact. Their participation underscores a shared commitment to accelerating translational research, clinical innovation, and capacity-building that contribute to regional and global health outcomes.โ
Dr. Emmanouil Dermitzakis, President of Qatar Precision Health Institute (QPHI) added: โOur partnership with Sidra Medicine for PMFG 2025 reflects a shared commitment to advancing precision health through innovation, collaboration, and real-world implementation. At QPHI, we believe that transforming healthcare begins with the integration of data, genomics, and technology to create impact at both the individual and population levels. PMFG serves as an essential platform where science meets strategy, driving the future of personalized medicine not only for Qatar but for the region and the world.โ
